Q14204 (DYHC1_HUMAN) Homo sapiens (Human)

Cytoplasmic dynein 1 heavy chain 1 UniProtKBInterProSTRINGInteractive Modelling

4646 aa; Sequence (Fasta) ; 2 identical sequences: Pongo abelii: A0A2J8SZT5; Nomascus leucogenys: G1S1B6

Available Structures

74 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Composite structure of dynein-dynactin-BICDR on microtubules Heteromer
A0A286ZK88; A0A287B8J2; A0A4X1TB62; A0A5G2QD80; A0JNT9; A0PFK5; A0PFK7; D0G6S1; F1SEC0; F2Z5G5; I3LHK5; O43237; Q13409; Q6QAQ1; Q9NP97;
20-4646
99.9613×ADP; 14×MG;ATP;ZN;ANP;
Composite structure of Dynein-Dynactin-JIP3-LIS1 Heteromer
A0A286ZK88; A0A287B8J2; A0A4X1TB62; A0A5G2QD80; A0PFK5; A0PFK7; D0G6S1; F1SEC0; F2Z5G5; I3LHK5; O43237; P43034; P63167; P63172; Q13409; Q6QAQ1; Q9NP97; Q9UPT6;
20-4646
99.9516×ADP;ATP;ZN;MG;ANP;
Composite structure of full-length human dynein-1 in phi-particle conformation Heteromer
O43237; P63167; P63172; Q13409; Q9NP97;
20-4645
100.0ADP;ATP;MG;
Cytoplasmic dynein light intermediate chain (B1) bound to the motor domain (A2). Heteromer
O43237;
1327-4646
99.93ADP;ATP;MG;ANP;
Cytoplasmic dynein-1 motor domain bound to dynactin-p150glued and LIS1 Heteromer
A0A287B8J2; P43034; Q13409;
1444-4646
99.93ADP;MG;ATP;
Cytoplasmic dynein-1 motor domain bound to LIS1 Heteromer
P43034;
1444-4646
99.93ADP;MG;ATP;
Cytoplasmic dynein-1 A1/A2 motor domains bound to LIS1 Heteromer
A0A287B8J2; P43034; Q13409;
1444-4646
99.93ADP;MG;ATP;
Engineered human dynein motor domain in the microtubule-unbound state with LIS1 complex in the buff… Heteromer
P43034;
1543-4645
100.0ATP;ADP;VO4;
Structure of human cytoplasmic dynein-1 bound to two Lis1 proteins Heteromer
P43034;
1652-4645
100.0ADP;ATP;
Structure of human cytoplasmic dynein-1 bound to one Lis1 Heteromer
P43034;
1674-4644
100.0ADP;ATP;
Engineered human dynein motor domain in the microtubule-unbound state with LIS1 complex in the buff… Heteromer
P43034;
2550-3800
100.0ADP;
Cryo-EM structure of two dynein tail domains bound to dynactin and BICDR1 Heteromer
A0A286ZK88; A0A5G2QD80; A0JNT9; A0PFK5; A0PFK7; D0G6S1; F2Z5G5; I3LHK5; O43237; Q13409; Q6QAQ1; Q9NP97;
20-1053
94.71ADP;ATP;
Cryo-EM structure of two dynein tail domains bound to dynactin and HOOK3 Heteromer
A0A286ZK88; A0A5G2QD80; A0PFK5; A0PFK7; D0G6S1; F1SL58; F2Z5G5; I3LHK5; O43237; Q13409; Q6QAQ1; Q9NP97;
20-1053
100.0ADP;ATP;
Cytoplasmic dynein (A1) bound to BICDR1 Heteromer
A0JNT9; F2Z5G5; O43237; Q13409;
210-1120
100.0
Cryo-EM structure of a single dynein tail domain bound to dynactin and BICD2N Heteromer
A0A286ZK88; A0A5G2QD80; A0PFK5; A0PFK7; D0G6S1; F2Z5G5; I3LHK5; O43237; Q13409; Q6QAQ1; Q9NP97;
20-914
100.0ADP;ATP;
Cytoplasmic dynein-B heavy chain bound to IC-LC tower Heteromer
O43237; P63167; P63172; Q13409; Q9NP97;
455-1347
100.0
Cytoplasmic dynein-1 heavy chain bound to JIP3-LZI Heteromer
O43237; Q13409; Q9UPT6;
177-1040
100.0
The barbed end complex of dynactin bound to BICDR1 and the cytoplasmic dynein tails (A2, B1, B2) Heteromer
A0A4X1T8I3; A0JNT9; A0PFK7; F2Z5G5; O43237; Q13409;
210-1028
100.0ADP;MG;
Cytoplasmic dynein (A2) bound to BICDR1 Heteromer
A0JNT9; O43237; Q13409;
259-1048
100.0
Cytoplasmic dynein-1 heavy chain bound to JIP3-RH1 Heteromer
O43237; Q13409; Q9UPT6;
258-1040
100.0
Cytoplasmic dynein-A heavy chain bound to dynactin-p150glued and IC-LC tower Heteromer
A0A287B8J2; O43237; P63167; P63172; Q13409;
830-1472
100.0
N terminal region of dynein tail domains in complex with dynactin filament and BICDR-1 Heteromer
A0A5G2QD80; A0JNT9; A0PFK5; A0PFK7; F2Z5G5; Q13409;
201-829
100.0ADP;
Dynein light intermediate chain region of the dynein tail/dynactin/BICDR1 complex Heteromer
O43237;
780-927
100
Human cytoplasmic Dynein N-Terminus dimerization domain at 1.8 Angstrom resolutionhomo-4-mer22-201
100.0GOL; 26×MG;CA;NA;K;
C terminal region of the dynein heavy chains in the dynein tail/dynactin/BICDR1 complexhomo-2-mer453-927
100
Cytoplasmic dynein-1 motor domainmonomer1327-4646
99.93ADP;ATP;MG;ANP;
State-8 of motor domain from full-length human dynein-1 in apo conditionmonomer1327-4646
100.0ATP;ADP;MG;
State-7-Post-1 of the motor domain from full-length human dynein-1 in 5mM AMPPNP with 5mM Mg2+monomer1327-4646
100.0ADP;ATP;ANP;MG;
Post-2 motor domain from full-length human dynein-1 bound to microtubules in 5mM ADP conditionmonomer1327-4646
100.0ADP;ATP;MG;
Motor domain from full-length human dynein-1 bound to microtubules in 5mM AMPPNP conditionmonomer1327-4646
100.0ADP;ATP;ANP;MG;
State-7a-post1 of motor domain from full-length human dynein-1 in 5 mM ADPmonomer1327-4646
100.0ADP;ATP;MG;
State-7b-post2 of motor domain from full-length human dynein-1 in 5 mM ADPmonomer1327-4646
100.0ADP;ATP;MG;
Motor domain from full-length human dynein-1 bound to microtubules in apo conditionmonomer1327-4646
100.0ATP;ADP;MG;
Post-1 motor domain from full-length human dynein-1 bound to microtubules in 5mM ADP conditionmonomer1327-4646
100.0ADP;ATP;MG;
State-7c of motor domain from full-length human dynein-1 in 5 mM ATPmonomer1327-4645
100.0ADP;ATP;
Cytoplasmic dynein-1 motor domain in post-powerstroke statemonomer1327-4610
99.93
Motor domains from human cytoplasmic dynein-1 in the phi-particle conformationmonomer1444-4646
100.0ADP;ATP;MG;
State-2 of the motor domain from full-length human dynein-1 in 5mM AMPPNP with 5mM Mg2+monomer1457-4645
100.0ADP;ATP;MG;
State-1 of the motor domain from full-length human dynein-1 in 5mM AMPPNP with 5mM Mg2+monomer1457-4645
100.0ADP;ATP;MG;
State-2 of motor domain from full-length human dynein-1 in 5mM ATPmonomer1457-4645
100.0ADP;ATP;MG;
State-1(phi motor) of full-length human dynein-1 in 5mM ATPVimonomer1457-4645
100.0AOV;ATP;ADP;MG;
State-2 of full-length human dynein-1 in 5mM ATPVimonomer1457-4645
100.0AOV;ATP;ADP;MG;
State-2 of the motor domain from full-length human dynein-1 in 5mM AMPPNPmonomer1457-4645
100.0ADP;ATP;MG;
State-1 of the motor domain from full-length human dynein-1 in 5mM AMPPNPmonomer1457-4645
100.0ADP;ATP;MG;
State-1 of motor domain from full-length human phi dynein-1 in 5 mM ADPmonomer1457-4645
100.0ADP;ATP;MG;
State-2 of motor domain from full-length human dynein-1 in 5 mM ADPmonomer1457-4645
100.0ADP;ATP;MG;
State-1 of motor domain from full-length human dynein-1 in apo conditionmonomer1457-4645
100.0ADP;ATP;MG;
State-1(phi motor) of full-length human dynein-1 in 5mM ATPmonomer1457-4645
100.0ADP;ATP;MG;
State-2 of motor domain from full-length human dynein-1 in apo conditionmonomer1457-4645
100.0ADP;ATP;MG;
State-7a of motor domain from full-length human dynein-1 in 5 mM ATPmonomer1460-4645
100.0ADP;ATP;MG;
State-7-Post-2 of the motor domain from full-length human dynein-1 in 5mM AMPPNP with 5mM Mg2+monomer1460-4645
100.0ADP;ATP;ANP;MG;
State-7 of motor domain from full-length human dynein-1 in apo conditionmonomer1461-4646
100.0ADP;ATP;MG;
State-7 of the motor domain from full-length human dynein-1 in 5mM AMPPNPmonomer1460-4645
100.0ADP;ATP;ANP;
Engineered human dynein motor domain in microtubule-bound statemonomer1463-4645
100.0ADP;ATP;
The alpha registry-locked dynein motor domain mutant in 5mM ATPVi condition, class1monomer1463-4645
99.97ADP;ATP;
The alpha registry-locked dynein motor domain mutant in 5mM ATP condition, class1monomer1463-4645
99.97ADP;ATP;
The alpha registry-locked dynein motor domain mutant in 5mM ATPVi condition, class2monomer1463-4645
99.97ADP;ATP;
The alpha registry-locked dynein motor domain mutant in 5mM ATP condition, class2monomer1463-4645
99.97ADP;ATP;
State-4 of motor domain from full-length human dynein-1 in 5 mM ATPmonomer1535-4645
100.0ADP;ATP;MG;
State-4 of the motor domain from full-length human dynein-1 in 5mM AMPPNP with 5mM Mg2+monomer1535-4645
100.0ADP;ATP;MG;
State-3 of motor domain from full-length human dynein-1 in 5mM ATPmonomer1535-4645
100.0ADP;ATP;MG;
State-4 of motor domain from full-length human dynein-1 in 5mM ATPVimonomer1535-4645
100.0AOV;ATP;ADP;MG;
State-4 of the motor domain from full-length human dynein-1 in 5mM AMPPNPmonomer1535-4645
100.0ADP;ATP;MG;
Engineered human dynein motor domain in the microtubule-unbound state in the buffer containing ATP-…monomer1543-4645
100.0ATP;ADP;VO4;MG;
State-7b of motor domain from full-length human dynein-1 in 5 mM ATPmonomer1615-4645
100.0ADP;ATP;
State-6 of motor domain from full-length human dynein-1 in 5 mM ATPmonomer1622-4645
100.0ADP;ATP;
State-5a of motor domain from full-length human dynein-1 in 5 mM ATPmonomer1622-4645
100.0ADP;ATP;
State-5 of the motor domain from full-length human dynein-1 in 5mM AMPPNP with 5mM Mg2+monomer1622-4645
100.0ADP;ATP;
State-5 of motor domain from full-length human dynein-1 in 5 mM ADPmonomer1622-4645
100.0ADP;ATP;
State-6 of motor domain from full-length human dynein-1 in 5 mM ADPmonomer1622-4645
100.0ADP;ATP;
State-5b of motor domain from full-length human dynein-1 in 5 mM ATPmonomer1622-4645
100.0ADP;ATP;MG;
State-6 of motor domain from full-length human dynein-1 in 5mM AMPPNPmonomer1622-4645
100.0ADP;ATP;
State-5 of motor domain from full-length human dynein-1 in 5mM AMPPNPmonomer1622-4645
100.0ADP;ATP;
Cytoplasmic dynein-1 motor domain AAA1, AAA2, and AAA3 subunitsmonomer1857-2955
100.0ADP;ATP;ANP;MG;

5 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7z8k.1.Amonomer0.73210-1120
100.00
7z8j.1.Bmonomer0.72267-1048
100.00
3err.1.Bmonomer0.723262-3441
92.22
9bmz.1.Amonomer0.701457-4645
ADP;100.00
5nug.1.Amonomer0.661444-4646
ADP;ATP;MG;100.00